Table 5. Characteristics of subjects taking part in the study.

PATIENT ID	SAMPLE DATE	AGE	GENDER	DIAGNOSIS/RILUZOLE
3	05/04/2012	57	M	ALS/R
4	12/04/2012	53	F	ALS/R
13	19/04/2012	72	M	ALS/-
7	26/04/2012	64	M	ALS/-
8	26/04/2012	60	M	ALS/-
16	11/05/2012	62	F	ALS/R
9	11/05/2012	63	F	ALS/R
17	12/06/2012	71	M	ALS/-

Table indicating patient and control IDs used for this study, as well as blood sample extraction date, age, gender, diagnosis and whether patient was treated with Riluzole. Controls that were matched to patients are also indicated (M = male, F = female, R = treated with Riluzole, P = partner, NBLD REL = non-blood relative). Samples from underlined patients and controls were used in PCR validation.